(於開曼群島註冊成立之有限公司) (股份代號: 587) 中期 報 告 20 14 /15 Hua Han Bio-Pharmaceutical Holdings Limited Hua Han Bio-Pharmaceutical Holdings Limited 華瀚生物製藥控股有限公司 Hua Han Bio-Pharmaceutical Holdings Limited 華瀚生物製藥控股有限公司 (Incorporated in the Cayman Islands with limited liability) (Stock Code: 587) In te rim Repor t 20 14 /15 華瀚生物製藥控股有限公司 Interim Report 2014/15 中期報告
1 2 4 5 7 8 9 22 44
(CPA, ACCA) Cricket Square Hutchins Drive P.O. Box 2681 Grand Cayman KY1-1111 Cayman Islands 168 200 34 3405 1 40 1 22 Royal Bank of Canada Trust Company (Cayman) Limited 4th Floor, Royal Bank House 24 Shedden Road, George Town Grand Cayman KY1-1110 Cayman Islands 183 22 1
3 1,124,090 1,363,601 (266,180) (320,444) 857,910 1,043,157 13,302 6,146 (441,894) (705,529) (56,989) (42,844) 5 (1,153) (783) 371,176 300,147 6 (63,528) (45,330) 7 307,648 254,817 8 2
298,860 247,293 8,788 7,524 307,648 254,817 9 7.3 6.5 7.3 6.5 3
307,648 254,817 (50,910) 46,549 256,738 301,366 250,119 289,637 6,619 11,729 256,738 301,366 4
1,089,695 472,024 28,546 28,964 106,730 123,110 51,221 51,651 110,273 110,273 18,883 18,885 368,843 370,557 1,064,375 959,313 33,835 34,202 2,872,401 2,168,979 71,426 43,239 10 701,535 917,018 541,855 17,293 5,467 5,523 2,029,234 2,725,335 3,349,517 3,708,408 11 50,636 59,494 178,358 121,320 31 37,479 37,794 197,914 173,498 147,441 611,828 392,137 2,737,689 3,316,271 5,610,090 5,485,250 5
48,691 48,944 9,994 12,598 58,685 61,542 5,551,405 5,423,708 12 409,558 408,408 4,932,368 4,812,440 5,341,926 5,220,848 209,479 202,860 5,551,405 5,423,708 6
408,408 1,417,112 46,959 100,781 526,515 7,992 (8,410) 2,574,464 147,027 5,220,848 202,860 5,423,708 298,860 298,860 8,788 307,648 (48,741) (48,741) (2,169) (50,910) (48,741) 298,860 250,119 6,619 256,738 1,150 20,654 (3,404) 18,400 18,400 (414) (147,027) (147,441) (147,441) 409,558 1,437,352 46,959 100,781 477,774 4,588 (8,410) 2,873,324 5,341,926 209,479 5,551,405 317,009 1,135,052 45,834 100,781 516,032 7,694 (8,410) 2,233,150 199,716 4,546,858 191,048 4,737,906 247,293 247,293 7,524 254,817 42,344 42,344 4,205 46,549 42,344 247,293 289,637 11,729 301,366 2,030 35,116 (7,694) 29,452 29,452 (1,279) (199,716) (200,995) (200,995) 319,039 1,168,889 45,834 100,781 558,376 (8,410) 2,480,443 4,664,952 202,777 4,867,729 7
527,243 52,756 (1,210,664) (435,618) 17,247 26,962 (666,174) (355,900) 2,725,335 2,799,436 (29,927) 24,092 2,029,234 2,467,628 2,029,234 2,467,628 8
1. 34 16 2 9
2. 10 10 12 12 27 27 19 19 27 27 32 32 39 39 21 10
2. 3. TIOT 1,101,493 1,262,190 1,005 101,411 6,615 TIOT 14,977 1,124,090 1,363,601 11
4. (i) (ii) TIOT (iii) TIOT (a) 12
4. (a) 1,102,548 6,615 14,927 1,124,090 375,933 3,396 1,498 380,827 (b) 380,827 (1,153) (8,498) 371,176 13
4. 90% 152,540,000 366,408,000 5. 1,153 775 8 1,153 783 14
6. 63,528 45,330 25% 15% 15% 15
7. 16,608 17,154 405 567 266,180 320,444 23,670 20,273 7,960 7,996 (10,782) (3,604) 8. 16
9. 298,860 247,293 4,088,363 3,187,750 22,715 2,648 4,111,078 3,190,398 17
10. 343,717 317,219 215,690 165,582 134,873 433,599 7,255 618 701,535 917,018 11. 42,454 41,309 1,109 5,089 2,712 9,826 4,361 3,220 50,636 59,494 18
12. 0.10 8,000,000,000 800,000 4,084,077,940 408,408 (a) 11,500,000 1,150 4,095,577,940 409,558 (a) 1.60 11,500,000 18,400,000 11,500,000 0.10 19
13. 362,865 62,850 62,990 723 731 63,573 426,586 232,763 235,278 296,336 661,864 3,240 3,247 20
14. 1,429 2,028 1,276 1,720 2,705 3,748 15. 16. Design Time Limited Driven Innovation Limited 620,000,000 2.2468 0.10 21
36,680 15.1% 12,528 23,325 13.3% 2,322 12.1% 2 15% 95% GDP GDP 22
GMP 23
2014 24
TIOT GMP 25
1,124,100,000 1,363,600,000 885,700,000 78.9% 7.2% 215,800,000 19.2% 30.0% 6,600,000 15,000,000 TIOT 1,000,000 298,900,000 20.9% 26
TIOT 27
28
14 10,00080 11,000 29
27 34 3 22 27 81 4 31 11 14 3 3 3 30
31
7,590 31,868 4.2 16.75% GDP GDP 5.5% 17.9% 9.7% 193 147 32
TIOT GMP OTC 33
1. HMO IT 34
2. 3. 35
4. GAP GMP 5. GMP GMP GMP GMP GMP 36
6. 7. 37
8. 9. 38
10. 11. 39
2,029,200,000 2,725,300,000 0.9% 0.7% 2,737,700,000 3,316,300,000 5.5 9.5 1,200,000 800,000 0.1% 0.1% 37,500,000 38,000,000 40
41
362,865 62,850 62,990 723 731 63,573 426,586 232,763 235,278 296,336 661,864 3,240 3,247 42
1,045 1,024 1,036 23,700,000 20,300,000 2.1% 1.5% 43
571 XV 7 8 352 10 1 1,063,942,495 (L) 2a 3,000,000 (L) 2b 25.98% 0.07% 44
1 3,000,000 (L) 2b 0.07% 3,000,000 (L) 2b 0.07% 3,000,000 (L) 2b 0.07% 82,944 (L) 0.002% 8,504,716 (L) 2c 0.21% 1,340,000 (L) 0.03% 1,880,000 (L) 2d 0.05% 45
1. L 2a. 1,063,942,495 Bull s-eye Limited BEL XV 7 8 BEL 2b. 1.60 2c. 8,504,716 3,000,000 (2b) 2d. 1,880,000 500,000 (2b) XV 7 8 352 46
18,600,000 0.38% 18,600,000 (a) (b) 3,000,000 3,000,000 3,000,000 3,000,000 3,000,000 3,000,000 3,000,000 3,000,000 1.60 1.69 1.60 1.69 1.60 1.69 1.60 1.69 3,000,000 (3,000,000) 3,000,000 (3,000,000) 1.60 1.69 1.60 1.69 3,000,000 3,000,000 3,000,000 (3,000,000) 3,000,000 (2,500,000) 500,000 1.60 1.69 1.60 1.69 1.60 1.69 27,000,000 (11,500,000) 15,500,000 47
(a) 1.60 (b) 48
XV 336 1 BEL 2 1,063,942,495 (L) 25.98% 3 1,066,942,495 (L) 26.05% Haw Par Pharmaceutical Holdings Pte. Ltd 589,162,536 (L) 14.39% 4 589,162,536 (L) 14.39% 411,264,000 (L) 10.04% Ample Cheer Limited 5 411,264,000 (L) 10.04% Best Forth Limited 6 411,264,000 (L) 10.04% 7 411,264,000 (L) 10.04% 49
XV 1. L 2. BEL XV 2 3 BEL BEL 3. XV 2 3 4. Haw Par Pharmaceutical Holdings Pte. Ltd. XV 2 3 Haw Par Pharmaceutical Holdings Pte. Ltd. 5. Ample Cheer Limited 100% XV 2 3 Ample Cheer Limited 6. Ample Cheer Limited Best Forth Limited 80% XV 2 3 Best Forth Limited Ample Cheer Limited 7. Best Forth Limited 100% XV 2 3 Best Forth Limited 336 50
14 10 51